Tharimmune Inc.

1.42
-0.01 (-0.70%)
At close: Mar 03, 2025, 3:59 PM
1.37
-3.52%
Pre-market: Mar 04, 2025, 09:25 AM EST

Tharimmune Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a
Operating Income -9.46M -6.88M -3.21M -1.81M -994.54K
Interest Income 152.63K n/a n/a n/a n/a
Pretax Income -9.32M -8.47M -2.21M -2.42M -1.53M
Net Income -9.32M -8.47M -2.21M -2.42M -1.53M
Selling & General & Admin 5.9M 4.6M 1.37M 671.88K 625.81K
Research & Development 3.56M 2.28M 1.84M 847.27K 368.73K
Other Expenses n/a n/a 1.83M -362.49K n/a
Operating Expenses 9.46M 6.88M 3.21M 1.52M 994.54K
Interest Expense 16.5K 1.59M 831.28K 246.53K 75.07K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 9.46M 6.88M 3.21M 1.52M 994.54K
Income Tax n/a -228.49K 831.28K -42.67K -171.86K
Shares Outstanding (Basic) 87.03K 30.18K 30.3K 27.45K 27.45K
Shares Outstanding (Diluted) 87.03K 30.18K 30.3K 27.45K 27.45K
EPS (Basic) -107.08 -280.77 -72.81 -88.05 -55.56
EPS (Diluted) -107.08 -280.77 -72.81 -88.05 -55.56
EBITDA -9.3M -6.88M -1.38M -1.88M -1.45M
Depreciation & Amortization 152.63K 228.49K 236.56K 206.3K 171.86K